Implanet (ALIMP) Stock Overview
A medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ALIMP Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Implanet S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.27 |
| 52 Week High | €0.45 |
| 52 Week Low | €0.08 |
| Beta | 0.97 |
| 1 Month Change | -31.82% |
| 3 Month Change | 62.16% |
| 1 Year Change | 124.07% |
| 3 Year Change | 55.17% |
| 5 Year Change | -64.66% |
| Change since IPO | -99.91% |
Recent News & Updates
Implanet S.A. (EPA:ALIMP) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Oct 30
Even With A 39% Surge, Cautious Investors Are Not Rewarding Implanet S.A.'s (EPA:ALIMP) Performance Completely
Aug 24Implanet S.A.'s (EPA:ALIMP) Subdued P/S Might Signal An Opportunity
Jul 02Recent updates
Implanet S.A. (EPA:ALIMP) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Oct 30Even With A 39% Surge, Cautious Investors Are Not Rewarding Implanet S.A.'s (EPA:ALIMP) Performance Completely
Aug 24Implanet S.A.'s (EPA:ALIMP) Subdued P/S Might Signal An Opportunity
Jul 02We Think Implanet (EPA:ALIMP) Has A Fair Chunk Of Debt
Oct 08Implanet (EPA:ALIMP) Is Carrying A Fair Bit Of Debt
Mar 21Shareholder Returns
| ALIMP | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 4.2% | 1.0% | -1.3% |
| 1Y | 124.1% | 41.7% | 8.6% |
Return vs Industry: ALIMP exceeded the French Medical Equipment industry which returned 43.5% over the past year.
Return vs Market: ALIMP exceeded the French Market which returned 9.7% over the past year.
Price Volatility
| ALIMP volatility | |
|---|---|
| ALIMP Average Weekly Movement | 19.1% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 10.0% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALIMP's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALIMP's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 46 | Ludovic Lastennet | www.implanet.com |
Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation.
Implanet S.A. Fundamentals Summary
| ALIMP fundamental statistics | |
|---|---|
| Market cap | €33.91m |
| Earnings (TTM) | -€4.81m |
| Revenue (TTM) | €11.10m |
Is ALIMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALIMP income statement (TTM) | |
|---|---|
| Revenue | €11.10m |
| Cost of Revenue | €6.21m |
| Gross Profit | €4.89m |
| Other Expenses | €9.70m |
| Earnings | -€4.81m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 44.04% |
| Net Profit Margin | -43.35% |
| Debt/Equity Ratio | -387.7% |
How did ALIMP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 06:56 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Implanet S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jean-Pierre Loza | In Extenso Financement & Marché |
| Sébastien Malafosse | ODDO BHF Corporate & Markets |